Cheng Cheng-Kuo, Wu Jender, Liu Yuan, Lee Tong-Sheng, Kang Shuo-Jhen, Sheu Ming-Thau, Lee Wen-Sen
Department of Ophthalmology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; Fu-Jen Catholic University, School of Medicine, Taipei, Taiwan.
Vascul Pharmacol. 2008 Feb-Mar;48(2-3):138-42. doi: 10.1016/j.vph.2008.01.007. Epub 2008 Feb 7.
Previously, we identified DPTH, an analogue of antiepileptic drug phenytoin (5,5-diphenylhydantoin, DPT), capable of retarding the cell cycle in the human vascular endothelial cells. Our data suggest that DPTH inhibits human umbilical venous endothelial cells (HUVEC) proliferation by increasing the level of p21 protein, which in turn inhibits the activities of cyclin-dependent kinase (CDK)2 and CDK4, and finally interrupts the cell cycle. To search chemicals with more potency in anti-angiogenic activity, we designed and synthesized several chemical compounds based on the structure-activity relationship consideration. We evaluated the anti-angiogenic activity of these compounds by examining their effects on DNA synthesis, cell number, p21 induction and capillary-like tube formation. Our results showed that introduction of side chain containing an aromatic ring structure with right spatial arrangement at sulfur atom of DPTH enhanced the anti-angiogenic activity in HUVEC.
此前,我们鉴定出了DPTH,它是抗癫痫药物苯妥英(5,5-二苯基乙内酰脲,DPT)的类似物,能够延缓人血管内皮细胞的细胞周期。我们的数据表明,DPTH通过提高p21蛋白水平来抑制人脐静脉内皮细胞(HUVEC)的增殖,这反过来又抑制了细胞周期蛋白依赖性激酶(CDK)2和CDK4的活性,最终中断细胞周期。为了寻找具有更强抗血管生成活性的化学物质,我们基于构效关系的考虑设计并合成了几种化合物。我们通过检测这些化合物对DNA合成、细胞数量、p21诱导和毛细血管样管形成的影响来评估它们的抗血管生成活性。我们的结果表明,在DPTH的硫原子上引入具有正确空间排列的含芳香环结构的侧链可增强其对HUVEC的抗血管生成活性。